Barely Significant
← all excerpts

Adding-on nivolumab to chemotherapy-stabilized patients is associated with improved survival in advanced pancreatic ductal adenocarcinoma.

Cancer Immunol Immunother · 2024 · PMC11383886 · PMID 39249118

Europe PMCDOI
1
hedged sentence
0.1000
closest p · 2.0× alpha
0.1000
boldest claim

The sentences

borderline significanceP < 0.1so close (0.05 < p ≤ 0.1)
Baseline characteristics (before nivolumab treatment) with borderline significance ( P < 0.1) in the univariate analysis were included in the multivariate analysis.

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.